Related Subjects:
|Chronic liver disease
|Cirrhosis
|Alkaline phosphatase (ALP)
|Liver Function Tests
|Ascites Assessment and Management
|Budd-Chiari syndrome
|Autoimmune Hepatitis
|Primary Biliary Cirrhosis
|Primary Sclerosing Cholangitis
|Wilson disease
|Hereditary Haemochromatosis
|Alpha-1 Antitrypsin (AAT) deficiency
|Non alcoholic steatohepatitis (NASH)
|Spontaneous Bacterial Peritonitis
|Alcoholism and Alcoholic Liver Disease
Wilson's disease accounts for 6โ12% of all acute liver failure cases referred for emergency liver transplantation. It should be suspected in any patient with unexplained liver disease or movement disorders of uncertain cause. Age alone must not be used to exclude the diagnosis.
๐ About
- Wilsonโs disease is an autosomal recessive disorder of copper metabolism.
- Prevalence ~1 in 30,000 live births; carrier frequency ~1 in 90.
- Untreated โ progressive copper accumulation in the liver, brain, cornea, and kidneys, leading to cirrhosis, neuropsychiatric decline, and early death.
- Early recognition and treatment are life-saving.
๐งฌ Aetiology
- Mutations in the ATP7B gene on chromosome 13 โ defective copper-transporting ATPase.
- Defect prevents copper excretion into bile and incorporation into caeruloplasmin.
- Over 200 ATP7B mutations have been identified worldwide.
KayserโFleischer rings (copper in Descemetโs membrane of the cornea) are a hallmark feature. Best seen on slit-lamp exam, but not entirely specific.
๐ฉบ Clinical Features
- Onset typically between ages 5โ45.
- Hepatic: hepatitis, cirrhosis, hepatosplenomegaly, jaundice, acute liver failure.
- Haematological: Coombs-negative haemolytic anaemia (free copper damages RBC membranes).
- Neurological: dysarthria, dystonia, rigidity, tremor, choreoathetosis (due to basal ganglia copper).
- Ophthalmic: KayserโFleischer rings, sunflower cataracts (posterior lens surface).
- Psychiatric: irritability, poor impulse control, depression, psychosis.
- Musculoskeletal: osteoporosis, rickets from chronic disease.
๐ Investigations
- Liver function: โ ALT/AST, prolonged PT in advanced disease.
- Haematology: Coombs-negative haemolysis.
- Biochemical markers:
- โ Serum caeruloplasmin (<0.2 g/L; <0.1 g/L highly specific).
- โ Free serum copper (>1.6 ยตmol/L).
- โ 24-hr urinary copper (>1.6 ยตmol/24h).
- โ Hepatic copper content (>250 ยตg/g dry weight).
- Ophthalmology: Slit lamp for KayserโFleischer rings.
- Renal: Tubular dysfunction โ proteinuria, glycosuria.
- MRI brain: basal ganglia/cerebellar changes, โgiant panda signโ.
- Genetics: ATP7B mutation testing confirms but complicated by heterogeneity.
The combination of KayserโFleischer rings + low caeruloplasmin (<0.1 g/L) is diagnostic.
๐ Management
- Untreated Wilsonโs disease is universally fatal.
- Copper chelation:
- D-penicillamine = first-line (but can cause lupus-like syndrome, nephrosis).
- Always give Pyridoxine (B6) with penicillamine.
- Trientine (triethylene tetramine) as alternative chelator.
- Zinc acetate: blocks intestinal copper absorption; safe for maintenance therapy.
- Dietary copper restriction (avoid shellfish, nuts, chocolate, mushrooms, liver).
- Liver transplantation: curative in fulminant hepatic failure or advanced cirrhosis.
๐ Reference